Literature DB >> 17920420

Biological enhancement of tibial diaphyseal aseptic non-unions: the efficacy of autologous bone grafting, BMPs and reaming by-products.

Nikolaos K Kanakaris1, Christos Paliobeis, Nikolaos Nlanidakis, Peter V Giannoudis.   

Abstract

The mandatory stimulus that can optimise the healing pathway can be electrical, mechanical, biological, or a combination of all these parameters. A variety of means has been utilised for biological enhancement, including extracorporeal shock wave, electrical, ultrasound stimulation, the reaming technique of IM nailing, bone graft substitutes, osteogenic cells and bioactive molecules produced by tissue engineering techniques. The aim of this study is to present a review of the existing evidence for the efficacy of reaming, autologous bone grafting and the commercially available growth factors (BMP-2 and BMP-7) for the treatment of aseptic tibial non-unions. The gold standard method of enhancing bone healing in cases of tibial non-union remains the autologous bone graft. Autogenous bone grafts possess osteoconductive, osteoinductive properties and also osteoprogenitor cells. However, their harvesting is associated with high morbidity and many complications reaching percentages of 30%. Intramedullary reamed nailing, either used as an alternative fixation method or as an exchange to a wider implant, offers the unique biomechanical advantages of an intramedullary device, together with the osteoinductive stimulus of the by-products of reaming, and the aptitude for early weight-bearing and active rehabilitation. The safety of administration of the commercial distributed growth factors (BMP-2 and BMP-7), combined with the lack of the morbidity and the quantity restrictions that characterise autologous bone grafts, have given to this family of molecules a principal role between the other bone graft substitutes. On average the union rates reported in the 20 manuscripts that have been evaluated range from 58.3% to 100%, and the average time to union from 12.5 weeks to 48.4 weeks, indicating the significant discrepancies in the reported evidence and the multiplicity of different treatment strategies.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17920420     DOI: 10.1016/s0020-1383(07)80011-8

Source DB:  PubMed          Journal:  Injury        ISSN: 0020-1383            Impact factor:   2.586


  14 in total

1.  Percutaneous management of ununited femoral fracture.

Authors:  F Ya'ish; A M Nanu; A T Cross
Journal:  Ann R Coll Surg Engl       Date:  2011-09       Impact factor: 1.891

2.  Effects of Bone Morphogenetic Protein-2 on Neovascularization During Large Bone Defect Regeneration.

Authors:  Hope B Pearson; Devon E Mason; Christopher D Kegelman; Liming Zhao; James H Dawahare; Melissa A Kacena; Joel D Boerckel
Journal:  Tissue Eng Part A       Date:  2019-06-14       Impact factor: 3.845

3.  Ethyl-3,4-dihydroxybenzoate with a dual function of induction of osteogenic differentiation and inhibition of osteoclast differentiation for bone tissue engineering.

Authors:  Byeong-Ju Kwon; Mi Hee Lee; Min-Ah Koo; Jae-Jin Han; Jong-Chul Park
Journal:  Tissue Eng Part A       Date:  2014-06-23       Impact factor: 3.845

4.  Systemically delivered insulin-like growth factor-I enhances mesenchymal stem cell-dependent fracture healing.

Authors:  Timothy J Myers; Yun Yan; Froilan Granero-Molto; Jared A Weis; Lara Longobardi; Tieshi Li; Ying Li; Clara Contaldo; Huseyin Ozkan; Huseyin Ozkhan; Anna Spagnoli
Journal:  Growth Factors       Date:  2012-05-04       Impact factor: 2.511

5.  Surgical treatment of aseptic forearm nonunion with plate and opposite bone graft strut. Autograft or allograft?

Authors:  Cesare Faldini; Francesco Traina; Fabrizio Perna; Raffaele Borghi; Matteo Nanni; Mohammadreza Chehrassan
Journal:  Int Orthop       Date:  2015-03-18       Impact factor: 3.075

6.  A cost analysis of treatment of tibial fracture nonunion by bone grafting or bone morphogenetic protein-7.

Authors:  Z Dahabreh; G M Calori; N K Kanakaris; V S Nikolaou; P V Giannoudis
Journal:  Int Orthop       Date:  2008-12-04       Impact factor: 3.075

7.  Stimulation of osteogenic differentiation in human osteoprogenitor cells by pulsed electromagnetic fields: an in vitro study.

Authors:  Justus H W Jansen; Olav P van der Jagt; Bas J Punt; Jan A N Verhaar; Johannes P T M van Leeuwen; Harrie Weinans; Holger Jahr
Journal:  BMC Musculoskelet Disord       Date:  2010-08-23       Impact factor: 2.362

8.  The synergistic effect of autograft and BMP-7 in the treatment of atrophic nonunions.

Authors:  Peter V Giannoudis; Nikolaos K Kanakaris; Rozalia Dimitriou; Ian Gill; Vinod Kolimarala; Richard J Montgomery
Journal:  Clin Orthop Relat Res       Date:  2009-04-24       Impact factor: 4.176

Review 9.  Efficacy of minimally invasive techniques for enhancement of fracture healing: evidence today.

Authors:  Ippokratis Pountos; Theodora Georgouli; George Kontakis; Peter V Giannoudis
Journal:  Int Orthop       Date:  2010-02       Impact factor: 3.075

Review 10.  Pulsed electromagnetic fields for the treatment of tibial delayed unions and nonunions. A prospective clinical study and review of the literature.

Authors:  Aggelos Assiotis; Nick P Sachinis; Byron E Chalidis
Journal:  J Orthop Surg Res       Date:  2012-06-08       Impact factor: 2.359

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.